Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $20.3000 (-3.45%) ($20.3000 - $20.3000) on Thu. Jan. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.16% (three month average) | RSI | 37 | Latest Price | $20.3000(-3.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -2.3% a day on average for past five trading days. | Weekly Trend | FOLD declines -2.4% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(53%) IWO(49%) XBI(48%) IWM(46%) IWC(44%) | Factors Impacting FOLD price | FOLD will decline at least -1.58% in a week (0% probabilities). VIXM(-28%) VXX(-13%) UUP(-11%) UNG(-6%) USO(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.58% (StdDev 3.16%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $14.06(-30.74%) | Resistance Level | $22.77 | 5 Day Moving Average | $21.68(-6.37%) | 10 Day Moving Average | $22.32(-9.05%) | 20 Day Moving Average | $22.77(-10.85%) | To recent high | -18.5% | To recent low | 14.9% | Market Cap | $5.242b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |